96684-40-1

Basic information

• Product Name: Piroxicambetadex
• Synonyms: Brexin; 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-,1,1-dioxide, compd with beta-cyclodextrin (2:5); Cicladol; Piroxicam-beta-cyclodextrin complex; beta-Cyclodextrin, compd with 4-hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide (5:2); a-Cyclodextrin,compd. with 4-hydroxy-2-methyl-N-2-pyridinyl-2H-1,- 2-benzothiazine-3-carboxamide 1,1-dioxide (5:2); Piroxicam betadex [USAN]; Brexicam
• CAS NO: 96684-40-1
• Molecular Formula: C₄₂H₇₀O₃₅? ₂/₅ C₁₅H₁₃N₃O₄S
• Molecular Weight: 1465.43
• Mol File: 96684-40-1.mol
• Article Data: 0

Chemical Properties

• CAS DataBase Reference: Piroxicambetadex(CAS DataBase Reference)
• NIST Chemistry Reference: Piroxicambetadex(96684-40-1)
• EPA Substance Registry System: Piroxicambetadex(96684-40-1)

Safety Data

• Hazardous Substances Data: 96684-40-1(Hazardous Substances Data)

Usage

General Description

Piroxicam betadex is a complex of piroxicam, a nonsteroidal anti-inflammatory drug (NSAID), with betadex, a cyclodextrin derivative. This complex is designed to enhance the solubility and bioavailability of piroxicam, allowing for improved drug delivery and effectiveness. Piroxicam betadex works by inhibiting the production of prostaglandins, which are key mediators of pain and inflammation. The combination of piroxicam with betadex also helps to reduce the risk of gastrointestinal irritation and bleeding commonly associated with NSAIDs. Overall, piroxicam betadex offers an effective and well-tolerated treatment option for conditions such as arthritis, musculoskeletal pain, and inflammation.